Ferring Pharmaceuticals and Karolinska Institutet have formed a collaboration agreement for the establishment of a research center exploiting the human microbiome. The program will be fully funded by Ferring Pharmaceuticals and governed by a joint steering committee. The proposed project focuses on therapeutic areas where Ferring has extensive expertise. Karolinska Institutet has a deep understanding of the human microbiome. Parts of the research will be carried out at the Science for Life La...